Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.
Industry News
eXmoor Pharma and Evox Therapeutics complete technology transfer programme for exosome-enabled gene editing technology
Jul 21, 2026
Industry News
eXmoor Pharma strengthens operational and technical leadership with two appointments
May 12, 2026
Industry News
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Apr 28, 2026
Industry News
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer to strengthen global commercial strategy
Mar 3, 2026
Industry News
Lucy Foley appointed to BioPhorum Strategic Advisory Board
Feb 6, 2026
Industry News
eXmoor Pharma and UCL forge a strategic collaboration to speed the advancement of cell and gene therapies
Dec 2, 2025
Industry News
eXmoor Pharma and Royal Free London launch strategic collaboration to strengthen UK cell and gene therapy manufacturing pathway
Nov 26, 2025
Industry News
eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading CGT services in Southeast Asia
Sep 23, 2025
Industry News
eXmoor Pharma and Anthony Nolan Cell Therapy and Laboratory Services to offer end-to-end support for cell therapy developers
Sep 2, 2025
Industry News